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Background: Pregabalin (PGB), an anticonvulsant, was studied throughout this work using spectrophotometric method.
Methods: The spectrophotometric method is based on the condensation reaction of PGB with
p-dimethylaminobenzaldehyde (pDMAB) in acid medium. The condensation product showed λmax at 420 nm.
Results: The different parameters affecting the stability of the condensation product were carefully studied and
optimized. The calibration plots were constructed over the concentration range of 40 to 120 μg ml−1.
Conclusions: A simple, reliable, sensitive and accurate spectrophotometric method has been developed for the
determination of an anticonvulsant drug, PGB. The proposed method was successfully applied to the analysis of the
drug in dosage form. The high sensitivity of the proposed method allows determination of PGB in bulk and in
pharmaceutical preparations.
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Pregabalin (PGB), (S)-3-(aminomethyl)-5-methyl hexanoic
acid is an antiepileptic and structurally related to the inhibi-
tory neurotransmitter aminobutyric acid (GABA). It is a
white crystalline solid with molecular formula C8H17NO2,
molecular mass of 159.23 g/mol and melting point from
190°C to 192°C. It was approved in the year 2007 for
adjunctive treatment of partial seizures in adults (Tassone
et al. 2007; Hamandi and Sander 2006; Barona et al. 2008)
in United States and Europe, and for the treatment of
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2013The wide use of this drug has prompted many researches
to develop sensitive and accurate analytical methods for its
determination, especially for routine quality control in the
analysis of pharmaceutical products. Several methods have
been developed for the determination of the drug in pure
and pharmaceutical preparations which are mostly based
on chromatographic, spectrofluorimetric and spectrophoto-
metric methods listed elsewhere (Bali and Gaur 2011). A
detailed literature survey shows that few spectrophotomet-
ric methods have been developed for the determination of
PGB in bulk and pharmaceutical preparation. A sensitive
and selective spectrophotometric method, based on the
reaction of the drug with 7-chloro-4-nitrobenzofuran, has
been developed for the determination of PGB by Onal and
Sagirli (2009). The relation between the absorbance of the
reaction product at 460 nm and the concentration is
rectilinear over the range 0.5 to 7.0 μg/ml. Gujral et al.
(2009) developed a simple and sensitive method for the
determination of PGB in bulk and pharmaceutical formula-
tions. The method is based on the reaction of the drug with
a mixture of potassium iodate and potassium iodide. The
method is linear over the range 0.5 to 3.5 μg/ml. Onal
(2009) developed three methods for the determination of
PGB in pharmaceutical preparations. Two methods are
based on the charge transfer complexation of the drug withn open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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8,8-tetracyanoquinodimethane (TCNQ), and the third
method was based on the reaction of ninhydrin with the
primary amine group on the drug molecule. While the first
two methods were linear over the concentration ranges of
2.0 to 30 and 1.5 to 10 μg/ml, respectively, the third
method was linear over a much wider concentration range
of 40 to 180 μg/ml. Two simple spectrophotometric
methods for the quantitative estimation of PGB in bulk and
pharmaceutical formulations were developed by Sowjanya
et al. (2011). The first method is based on the condensation
of PGB with 1,2-naphthaquinone-4-sulfonic acid sodium in
alkaline medium, and the second method is based on the
oxidation of 2,4-dinitrophenyhydrazine and the coupling of
the oxidation product with the drug to give intensely
coloured chromogen. The first method is linear over the
concentration range of 5 to 45 μg/ml, and the second
method is linear over the range of 50 to 450 μg/ml. Reddy
(2013) developed a spectrophotometric method for deter-
mination of PGB in bulk and pharmaceutical dosage form.
The method is based on the reaction of PGB with DDQ to
form red colour charge-transfer complex. Beer's law is
obeyed in the concentration range of 50 to 250 μg/ml for
the method. UV-visible spectroscopy is the technique of
choice for the accurate and cost-effective determination of
pharmaceutical compounds especially in third world coun-
tries. Consequently, there is scope for the development of
simple and accurate spectrophotometric methods for the



















Figure 1 UV-visible spectrum of the product of PGB and pDMAB (λmaIn this study, p-dimethylaminobenzaldehyde (pDMAB)
has been used as a chromogenic agent for the determin-
ation of pregabalin. pDMAB possesses some peculiar struc-
tural features which account for its applicability in a wide
range of reactions and processes. Its condensation reactions
have been utilized for the spectrophotometric determin-
ation of many drugs (Adegoke and Umoh 2009; Adegoke
and Nwoke 2008). An attempt has been made to develop a
simple, accurate, rapid and economical method for
determination of pregabalin in pure and pharmaceutical
formulations. The method is based on the reaction of preg-
abalin with pDMAB in acidic medium. The method
involves a one-step reaction, does not involve any extrac-
tion or heating steps and does not require any costly
chemicals and equipment. The reaction is monitored
spectrophotometrically, and the change in absorbance with
time is measured at 420 nm.
Methods
Instrumentation
A Systronics UV-visible spectrophotometer (model 118,
Gujarat, India) with 1-cm matched quartz cells was used
for the absorbance measurements. Shimadzu electronic
balance (Kyoto, Japan) was used for weighing the samples.
Materials
All the chemicals and materials were of analytical grade
and were purchased from Qualigens Fine Chemicals
Pvt. Ltd. (Mumbai, India), and Deccan Fine Chemicals
India Limited (Hyderabad, India). All the solutions were500 600 700
ength (nm)
x 420 nm).
Scheme 1 Probable mechanism of the reaction between pDMAB and PGB in acid medium.
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Himedia Laboratories (Mumbai, India), and PGB 75
capsules (label amount 75 mg PGB/capsule) of various
pharmaceutical manufactures were purchased from the
market.Preparation of the standard solutions
Stock solution of PGB (1,000 μg/ml) was prepared by
dissolving 100 mg of drug in 10 ml of 0.5 M H2SO4 and
diluting up to the mark by ethanol in a 100-ml
calibrated flask. The stock solution was further diluted
appropriately to get working concentrations. pDMAB
(0.3% w/v) was made by dissolving 0.3 g in 100 ml of
0.5 M H2SO4.General procedure
Construction of calibration curve
To a set of 10-ml volumetric flasks, appropriate aliquots of
the standard working solution were transferred to obtain
concentrations in the range 40 to 120 μg ml−1 of PGB.
Aliquots of standard solution of pregabalin were mixed
with 2 ml of 0.3% pDMAB, and the contents were diluted
up to 10 ml with ethanol and time was noted. The reaction
mixture was rapidly transferred into a cuvette, and absorb-
ance at 420 nm was recorded after every 5 min against the
reagent blank prepared simultaneously in the same manner
without the analyte. First, absorbance was taken exactly
5 min after mixing PGB and pDMAB solutions. The
procedure was repeated for different concentrations of the
drug solution, with a constant concentration of pDMAB





















Figure 2 Variation of absorbance of drug-reagent mixture with time. (a) 40 μg/ml, (b) 60 μg/ml, (c) 80 μg/ml, (d) 100 μg/ml, and
(e) 120 μg/ml.
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temperature. The regression equations of calibration graphs
were calculated using the method of least squares.
Assay of capsules
An accurately weighed portion of powder from tablets
purchased from open market equivalent to 100 mg of PGB















Figure 3 Effect of acid concentration on absorbance of drug-reagentH2SO4 and was diluted up to the mark using ethanol. It
was shaken thoroughly for about 5 to 10 min, filtered
through a Whatman paper to remove insoluble matter and
used to prepare 1,000 μg/ml using ethanol for dilution. An
aliquot of this solution was diluted with ethanol to obtain a
required concentration (40 to 120 μg/ml). Then, to a
solution of particular concentration, 2 ml of 0.3% pDMAB



















Figure 4 Effect of concentration of pDMAB on absorbance of drug-reagent mixture.
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capsules was determined using the corresponding regres-
sion equations or the calibration graphs.
Results and discussions
In an effort to develop a spectrophotometric method for
quantification of pregabalin, its reaction with pDMAB in
an acid medium for the generation of a chromophoric
product was studied. PGB reacts instantly with pDMAB in
an acid medium to give a light yellow colour (λmax at





















Figure 5 Calibration plot of the initial rate of reaction versus drug coabsorb in the visible region at all, while pDMAB shows
λmax at 280 nm. The UV-visible spectrum of the product
of the reaction between PGB and pDMAB is given in
Figure 1. The probable mechanism of the reaction
between pDMAB and PGB in acid medium is given in
Scheme 1.
The condensation reaction requires the presence of an
acid for the protonation of the carbonyl oxygen and thereby
leaving the carbonyl carbon fully positively charged. The
PGB then donates a lone pair of electrons to the carbon.
Internal rearrangement thereafter results in the formation60 80 100 120
entration( g/ml)
ncentration.




















Log of drug concentration
Figure 6 Plot of log of reaction rate versus log of drug concentration (mol/l).
Figure 7 Calibration plots of absorbance versus drug
concentration at fixed time. (a) 5 min, (b) 10 min, (c) 15 min, (d)
20 min, (e) 25 min, (f) 30 min, (g) 35 min, (h) 40 min, (i) 45 min,
and (j) 50 min.
Najam et al. Journal of Analytical Science and Technology Page 6 of 92013, 4:22
http://www.jast-journal.com/content/4/1/22of condensation product, giving water and H+ as by-
product. The intensity of colour decreases with time
(Figure 2) and provides a basis for kinetic study. The
decrease in the intensity of yellow colour and hence absorb-
ance is perhaps due to partial decomposition of the reaction
product into the reagents on standing. This was confirmed
by measuring the λmax of the reaction mixture at different
time intervals, viz., 5, 15, 30, 65 min, after mixing the
reagents. The λmax has been found to remain unchanged at
420 nm. The rate of reaction was monitored spectrophoto-
metrically at 420 nm at room temperature with various
concentrations of the drug, while pDMAB was kept in
excess and constant.
Optimization of reaction conditions
Effect of acid concentration
The stability of the condensation product was checked with
HCl, HNO3, oxalic acid and H2SO4. The best results were
obtained when H2SO4 was used. After selecting H2SO4, the
stability was checked with its varying concentrations. Lower
acid concentrations gave low absorbance values, while
absorbance declined with increasing acid concentrations
beyond 0.5 M H2SO4. The best results were obtained with
0.5 M H2SO4 (Figure 3). For the sake of ease, the
experiments were carried out with ≈ 500-μg/ml drug
concentration.
Effect of pDMAB concentration
It was found that the reaction is dependent on the pDMAB
concentration. The absorbance of the reaction solution
increases as the reagent concentration increases, and thehighest absorption intensity is attained at 0.3% (w/v)
reagent concentration. A higher reagent concentration up
to 1% has no effect on the absorption values. Further
experiments were carried out using 0.3% (w/v) of the
reagent. The results obtained are shown in Figure 4. The
experiments were carried out with ≈ 600-μg/ml drug
concentration.Reaction rate method
A plot of the initial rate of reaction versus concentration
of the drug (Figure 5) gives a straight line and serves as a
Table 1 Regression equations for the reaction rate and fixed time methods for the determination of pregabalin
Method Regression equation r2
Reaction rate method Rate = 2.8 × 10−4 + 2.48 × 10−4 × drug concentration 0.999
Fixed time method, time (min)
5 A = 0.00106 + 0.00123 × drug concentration 0.999
10 A = −0.0032 + 0.00111 × drug concentration 0.999
15 A = −0.0038 + 0.00103 × drug concentration 0.999
20 A = 0.0052 + 7.2 × 10−4 × drug concentration 0.993
25 A = 0.0036 + 6.4 × 10−4 × drug concentration 0.999
30 A = 0.0034 +5.6 × 10−4 × drug concentration 0.992
35 A = 0.003 + 4.9 × 10−4 × drug concentration 0.989
40 A = 0.0032 + 4.4 × 10−4 × drug concentration 0.984
45 A = 0.0026 + 3.8 × 10−4 × drug concentration 0.979
50 A = 0.0046 + 2.9 × 10−4 × drug concentration 0.993
A Absorbance.
The drug concentration is represented in μg/ml.
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from the variable time method (Presez-Bendito and Silva
1988; Martin and Bustamante 1993) of measurement as
ΔA / Δt, where A is the absorbance, and t is the time in
seconds. In the present study, ΔA / Δt was obtained byTable 2 Evaluation of accuracy and precision by the proposed
preparations
Method Amount taken (μg/ml) Amo





















aAn average of six determinations.dividing the absorbance measured 300 s (5 minutes) after
mixing the drug and the reagent solutions by 300 s,
assuming that the absorbance of the coloured product at
t = 0 is zero. The regression equation for the reaction rate-
versus-concentration (μg/ml) graph ismethod: determination of PGB in pharmaceutical
unta found (μg/ml) %Recovery SD RSD (%)
39.32 98.3 1.071 2.7
59.08 98.46 1.318 2.2
80.58 100.7 1.714 2.1
96.04 96.04 2.210 2.3
120.64 100.53 0.724 0.6
39.92 99.8 1.081 2.5
59.83 99.7 1.325 2.2
81.51 101.89 1.756 2.1
97.09 97.09 2.22 2.2
121.89 101.5 0.72 0.5
40.10 100.25 1.085 2.6
58.28 97.13 0.492 0.8
80.20 100.25 1.750 2.1
99.87 99.87 1.356 1.3
120.6 100.5 0.734 0.6
40.90 102.25 0.50 1.2
57.72 96.21 1.004 1.7
82.32 102.9 2.129 2.5
101.25 101.25 1.337 1.3
119.70 99.75 0.811 0.6
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r2 ¼ 0:999:
A plot of log of reaction rate versus log of drug concen-
tration gives a straight line (Figure 6) which shows that the
reaction rate of the drug obeys the following equation:
Rate ¼ K′ drug½ n; ð1Þ
where K′ is the rate constant, n is the order of the reaction
and the drug concentration is in mol/L.
Taking logarithms of Equation (1),
Log rate ¼ logK′þ n log drug½ 
LogΔA=Δt ¼ logK′þ n log drug½ 
LogΔA=Δt ¼ −3:5664þ 0:98 log drug½ ;
r2 ¼ 0:999:
Thus, K′ = 0.00027, and the reaction is first order
(n = 0.98) with respect to drug concentration.
Fixed time method
Change in absorbance with time was followed for different
concentrations of the drug. At a fixed time, which was
accurately determined, the absorbance was measured.
Calibration graphs of absorbance versus initial concentra-
tions of the drug at fixed times of 5, 10, 15, 20,…, 50 min
were drawn (Figure 7). The correlation coefficients of the
curves were calculated. The regression equations for the
calibration graphs corresponding to different fixed times
are given in Table 1.
Validation of the proposed methods
Two different methods were tried to construct the calibra-
tion curves for the determination of the drug from the rate
data, reaction rate method and fixed time method. The
regression equations were calculated for every calibration
curve. It is evident that in both methods, there is an excel-
lent correlation between the analytical parameter and the
concentration of the drug. The high correlation coefficients
(r2) obtained for most of the calibration curves indicate
high linearity in the range 40 to 120 μg/ml, and hence,
these are suitable methods for the assay of the drug. The
above methods were performed in the concentration range
of 40 to 120 μg/ml. At higher concentrations, Beer's law is
not obtained.
Precision and accuracy
The precision, accuracy and the applicability of the pro-
posed methods were evaluated by measuring five independ-
ent samples of pregabalin in pharmaceutical preparations
(tablet form) at 40, 60, 80, 100 and 120-μg/ml drug concen-
trations. Six replicate measurements were made for each
concentration. The precision and accuracy were evaluated
in terms of the standard deviation and percent recovery.
The results are given in Table 2. The calculated relativestandard deviations are around 2% for most of the concen-
trations studied (except for 40 μg/ml where it reaches up to
2.7%), indicating excellent precision of the proposed
methods. The percent recovery has been between 96.04%
and 102.9%, indicating a close agreement between the
measured and true values. Hence, the proposed methods
will be effective for the determination of pregabalin in
pharmaceutical formulations. The condensation reaction
between the drug and the reagent involves the primary
aliphatic amine group. The absence of primary aliphatic
amine group in the common excipients of the drug namely
lactose monohydrate, talc, gelatin, maize starch and glucose
eliminates any chances of interferences in the determin-
ation of the drug because of their inability to react with the
reagent. The excellent RSD and %recovery values obtained
with samples of pharmaceutical formulations confirm that
there is no potential interference of these excipients on the
proposed methods.
Conclusion
The proposed methods are simple which preclude any
use of harmful and costly solvents and reagents.
&b_k'p-Dimethylaminobenzaldehyde is a suitable
reagent for the spectrophotometric determination of
pregabalin. It is not only cheap and safe but also is
available in any analytical laboratory with excellent shelf
life. The procedure of the proposed methods is simple
and time saving. No tedious procedures, extractions,
heating and long standing times etc. are involved. The
proposed method is sensitive, accurate and reprodu-
cible; requires simple apparatus for its performance; and
consequently is suitable for routine quality control of
the drug.
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